FDA Signals It’s Open To Drug Trials That Shift Midcourse
Unfortunately, you’ll need a subscription to read this WSJ article. Fortunately, I can summarize it in one sentence. The FDA is finally planning to release a guidance for the design, conduct and analysis of adaptive clinical trials. And my one-sentence commentary: It’s about freakin’ time.
